Smartwatch-Guided heart pills aim to keep AFib patients out of hospital
NCT ID NCT07445789
Summary
This study aims to see if the heart medication verapamil works better than the more commonly used metoprolol at controlling heart rate in people with a type of irregular heartbeat called paroxysmal atrial fibrillation (AFib). It will involve 436 adults with symptomatic AFib who need heart rate control. A smaller group will also test if using a smartwatch to guide their medication dose helps them manage their condition better, with the goal of reducing hospital visits and procedures.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.